EDITAS MEDICINE INC (EDIT) Earnings History & Surprises
NASDAQ:EDIT • US28106W1036
2.44 USD
-0.1 (-3.94%)
At close: Mar 13, 2026
2.46 USD
+0.02 (+0.82%)
After Hours: 3/13/2026, 8:22:26 PM
Past quarterly earnings results for EDITAS MEDICINE INC (EDIT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMay 11, 2026
PeriodQ1 / 2026
EPS Estimate-$0.30
Revenue Estimate2.623M
Last Reported
Release DateMar 9, 2026
PeriodQ4 / 2025
EPS Reported-$0.06
EPS Surprise 77.22%
Revenue Surprise 333.52%
Beat Rate
44%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.06 | -0.26 | 77.22% | 89.09% | 24.741M | 5.707M | 333.52% | -19.16% |
| Q3 2025 | -0.28 | -0.30 | 7.33% | 62.67% | 7.543M | 5.12M | 47.32% | 12,265.57% |
| Q2 2025 | -0.63 | -0.38 | -63.79% | 23.17% | 3.578M | 1.703M | 110.10% | 597.47% |
| Q1 2025 | -0.92 | -0.60 | -53.11% | -21.05% | 4.658M | 720.12K | 546.84% | 310.40% |
| Q4 2024 | -0.55 | -0.36 | -51.16% | -139.13% | 30.604M | 32.875M | -6.91% | -49.03% |
| Q3 2024 | -0.75 | -0.76 | 1.53% | -36.36% | 61K | 2.289M | -97.34% | -98.86% |
| Q2 2024 | -0.82 | -0.72 | -14.27% | -46.43% | 513K | 5.185M | -90.11% | -82.23% |
| Q1 2024 | -0.76 | -0.68 | -12.10% | -7.04% | 1.135M | 8.063M | -85.92% | -88.48% |
| Q4 2023 | -0.23 | -0.55 | 58.41% | 73.86% | 60.048M | 8.102M | 641.15% | 818.17% |
| Q3 2023 | -0.55 | -0.58 | 5.09% | 32.10% | 5.336M | 3.488M | 52.98% | 13,240.00% |
| Q2 2023 | -0.56 | -0.78 | 28.06% | 28.21% | 2.887M | 4.254M | -32.13% | -54.61% |
| Q1 2023 | -0.71 | -0.80 | 11.21% | 4.05% | 9.851M | 3.068M | 221.09% | 45.51% |
| Q4 2022 | -0.88 | -0.82 | -7.53% | -44.26% | 6.54M | 3.323M | 96.81% | -47.55% |
| Q3 2022 | -0.81 | -0.89 | 8.60% | -42.11% | 40K | 4.801M | -99.17% | -99.35% |
| Q2 2022 | -0.78 | -0.84 | 6.94% | 3.70% | 6.36M | 4.376M | 45.34% | 1,573.68% |
| Q1 2022 | -0.74 | -0.81 | 8.76% | 13.95% | 6.77M | 3.93M | 72.26% | 4.15% |
| Q4 2021 | -0.61 | -0.74 | 17.05% | 39.00% | 12.47M | 4.372M | 185.22% | 9.19% |
| Q3 2021 | -0.57 | -0.83 | 31.53% | -575.00% | 6.2M | 4.872M | 27.26% | -90.13% |
| Q2 2021 | -0.81 | -0.84 | 3.98% | -88.37% | 380K | 6.299M | -93.97% | -96.47% |
| Q1 2021 | -0.86 | -0.75 | -14.81% | -24.64% | 6.5M | 5.891M | 10.34% | 13.64% |
| Q4 2020 | -1.00 | -0.75 | -33.14% | - | 11.42M | 5.756M | 98.40% | - |
| Q3 2020 | 0.12 | -0.65 | 118.50% | - | 62.84M | 6.732M | 833.45% | - |
| Q2 2020 | -0.43 | -0.82 | 47.74% | - | 10.75M | 6.462M | 66.36% | - |
| Q1 2020 | -0.69 | -0.80 | 14.06% | - | 5.72M | 6.86M | -16.62% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-40.18%
Max EPS beat (4)
7.33%
Min EPS beat (4)
-63.79%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
174.34%
Max Revenue beat (4)
546.84%
Min Revenue beat (4)
-6.91%
Analysis
In the last 4 quarters, EDIT has beaten EPS estimates in 1 out of 4 releases
EDIT has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, EDIT reported -40.2% below the EPS estimates on average.
In the last 4 quarters, EDIT has beaten the revenue estimates by 174.3% on average.
EDITAS MEDICINE INC / EDIT Earnings FAQ
Can you provide the last earnings date for EDITAS MEDICINE INC?
EDITAS MEDICINE INC (EDIT) last reported earnings on 3/9/2026.
Did EDIT stock beat earnings estimates in the most recent quarter?
EDITAS MEDICINE INC (EDIT) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does EDITAS MEDICINE INC (EDIT) beat earnings estimates?
In the last 4 quarters, EDITAS MEDICINE INC (EDIT) has beaten EPS estimates in 1 out of 4 releases.